Affect Therapeutics
New York, NY
Affect Therapeutics offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. They provides treatments for a variety of substance use disorders. The program provides financial incentives to encourage healthy behaviors and new habits.
affecttherapeutics.comCompany Details
Founded
- 2020
Employees
- Between 50 - 200 employees
Raised
- $23,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Kristin Muhlner
Founders
- Jeffrey De Flavio, MDKristin MuhlnerRachel LinKevin Ryan
Company Collections
These are collections Affect Therapeutics is a part of. Click on the collection name to view similar companies.
Affect Therapeutics' Investors
Affect Therapeutics' Industries
Company Collections For Affect Therapeutics
Affect Therapeutics Headquarters Location
520 Broadway 4th Floor, New York, NY 10012
Total Amount Raised: $23,000,000
Affect Therapeutics' Investors
Affect Therapeutics Funding Rounds
Series A
$16,000,000
Series A Investors
Artis VenturesKapor CapitalWhat If VenturesSamsung NextCity Light CapitalAlleyCorpLifeArc VenturesSeed
$6,000,000
Seed Investors
Kapor CapitalCity Light CapitalAlleyCorpAcumen AmericaSeed
$1,000,000
Seed Investors
AlleyCorp
Funding info provided by Diffbot.
Affect Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Affect Therapeutics.